0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ab De Novo Sequencing Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-37K13513
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Ab De Novo Sequencing Market Research Report 2023
BUY CHAPTERS

Global Ab De Novo Sequencing Market Research Report 2025

Code: QYRE-Auto-37K13513
Report
May 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Ab De Novo Sequencing Market

The global market for Ab De Novo Sequencing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Ab De Novo Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Ab De Novo Sequencing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Ab De Novo Sequencing in Academic and Research Institutions is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Ab De Novo Sequencing include Nanjing Mingyan Biotechnology Co., Ltd., Suzhou Jinweizhi Biotechnology Co., Ltd., Beijing Baitai Parker Biotechnology Co., Ltd., Biocompare, Abveris, Rapid Novor, GenScript, Absolute Antibody, Curia Global, ProteoGenix, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Ab De Novo Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ab De Novo Sequencing.
The Ab De Novo Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ab De Novo Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ab De Novo Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Ab De Novo Sequencing Market Report

Report Metric Details
Report Name Ab De Novo Sequencing Market
Segment by Type
  • Monoclonal Antibodies
  • Polyclonal Antibodies
Segment by Application
  • Academic and Research Institutions
  • Pharmaceutical and Biotech Companies
  • Diagnostic and Clinical Laboratories
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Nanjing Mingyan Biotechnology Co., Ltd., Suzhou Jinweizhi Biotechnology Co., Ltd., Beijing Baitai Parker Biotechnology Co., Ltd., Biocompare, Abveris, Rapid Novor, GenScript, Absolute Antibody, Curia Global, ProteoGenix, CiteAb, BIOZOL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Ab De Novo Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Ab De Novo Sequencing Market report?

Ans: The main players in the Ab De Novo Sequencing Market are Nanjing Mingyan Biotechnology Co., Ltd., Suzhou Jinweizhi Biotechnology Co., Ltd., Beijing Baitai Parker Biotechnology Co., Ltd., Biocompare, Abveris, Rapid Novor, GenScript, Absolute Antibody, Curia Global, ProteoGenix, CiteAb, BIOZOL

What are the Application segmentation covered in the Ab De Novo Sequencing Market report?

Ans: The Applications covered in the Ab De Novo Sequencing Market report are Academic and Research Institutions, Pharmaceutical and Biotech Companies, Diagnostic and Clinical Laboratories, Other

What are the Type segmentation covered in the Ab De Novo Sequencing Market report?

Ans: The Types covered in the Ab De Novo Sequencing Market report are Monoclonal Antibodies, Polyclonal Antibodies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ab De Novo Sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Polyclonal Antibodies
1.3 Market by Application
1.3.1 Global Ab De Novo Sequencing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Academic and Research Institutions
1.3.3 Pharmaceutical and Biotech Companies
1.3.4 Diagnostic and Clinical Laboratories
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ab De Novo Sequencing Market Perspective (2020-2031)
2.2 Global Ab De Novo Sequencing Growth Trends by Region
2.2.1 Global Ab De Novo Sequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Ab De Novo Sequencing Historic Market Size by Region (2020-2025)
2.2.3 Ab De Novo Sequencing Forecasted Market Size by Region (2026-2031)
2.3 Ab De Novo Sequencing Market Dynamics
2.3.1 Ab De Novo Sequencing Industry Trends
2.3.2 Ab De Novo Sequencing Market Drivers
2.3.3 Ab De Novo Sequencing Market Challenges
2.3.4 Ab De Novo Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ab De Novo Sequencing Players by Revenue
3.1.1 Global Top Ab De Novo Sequencing Players by Revenue (2020-2025)
3.1.2 Global Ab De Novo Sequencing Revenue Market Share by Players (2020-2025)
3.2 Global Ab De Novo Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Ab De Novo Sequencing Revenue
3.4 Global Ab De Novo Sequencing Market Concentration Ratio
3.4.1 Global Ab De Novo Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ab De Novo Sequencing Revenue in 2024
3.5 Global Key Players of Ab De Novo Sequencing Head office and Area Served
3.6 Global Key Players of Ab De Novo Sequencing, Product and Application
3.7 Global Key Players of Ab De Novo Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Ab De Novo Sequencing Breakdown Data by Type
4.1 Global Ab De Novo Sequencing Historic Market Size by Type (2020-2025)
4.2 Global Ab De Novo Sequencing Forecasted Market Size by Type (2026-2031)
5 Ab De Novo Sequencing Breakdown Data by Application
5.1 Global Ab De Novo Sequencing Historic Market Size by Application (2020-2025)
5.2 Global Ab De Novo Sequencing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Ab De Novo Sequencing Market Size (2020-2031)
6.2 North America Ab De Novo Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Ab De Novo Sequencing Market Size by Country (2020-2025)
6.4 North America Ab De Novo Sequencing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ab De Novo Sequencing Market Size (2020-2031)
7.2 Europe Ab De Novo Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Ab De Novo Sequencing Market Size by Country (2020-2025)
7.4 Europe Ab De Novo Sequencing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ab De Novo Sequencing Market Size (2020-2031)
8.2 Asia-Pacific Ab De Novo Sequencing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Ab De Novo Sequencing Market Size by Region (2020-2025)
8.4 Asia-Pacific Ab De Novo Sequencing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ab De Novo Sequencing Market Size (2020-2031)
9.2 Latin America Ab De Novo Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Ab De Novo Sequencing Market Size by Country (2020-2025)
9.4 Latin America Ab De Novo Sequencing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ab De Novo Sequencing Market Size (2020-2031)
10.2 Middle East & Africa Ab De Novo Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Ab De Novo Sequencing Market Size by Country (2020-2025)
10.4 Middle East & Africa Ab De Novo Sequencing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nanjing Mingyan Biotechnology Co., Ltd.
11.1.1 Nanjing Mingyan Biotechnology Co., Ltd. Company Details
11.1.2 Nanjing Mingyan Biotechnology Co., Ltd. Business Overview
11.1.3 Nanjing Mingyan Biotechnology Co., Ltd. Ab De Novo Sequencing Introduction
11.1.4 Nanjing Mingyan Biotechnology Co., Ltd. Revenue in Ab De Novo Sequencing Business (2020-2025)
11.1.5 Nanjing Mingyan Biotechnology Co., Ltd. Recent Development
11.2 Suzhou Jinweizhi Biotechnology Co., Ltd.
11.2.1 Suzhou Jinweizhi Biotechnology Co., Ltd. Company Details
11.2.2 Suzhou Jinweizhi Biotechnology Co., Ltd. Business Overview
11.2.3 Suzhou Jinweizhi Biotechnology Co., Ltd. Ab De Novo Sequencing Introduction
11.2.4 Suzhou Jinweizhi Biotechnology Co., Ltd. Revenue in Ab De Novo Sequencing Business (2020-2025)
11.2.5 Suzhou Jinweizhi Biotechnology Co., Ltd. Recent Development
11.3 Beijing Baitai Parker Biotechnology Co., Ltd.
11.3.1 Beijing Baitai Parker Biotechnology Co., Ltd. Company Details
11.3.2 Beijing Baitai Parker Biotechnology Co., Ltd. Business Overview
11.3.3 Beijing Baitai Parker Biotechnology Co., Ltd. Ab De Novo Sequencing Introduction
11.3.4 Beijing Baitai Parker Biotechnology Co., Ltd. Revenue in Ab De Novo Sequencing Business (2020-2025)
11.3.5 Beijing Baitai Parker Biotechnology Co., Ltd. Recent Development
11.4 Biocompare
11.4.1 Biocompare Company Details
11.4.2 Biocompare Business Overview
11.4.3 Biocompare Ab De Novo Sequencing Introduction
11.4.4 Biocompare Revenue in Ab De Novo Sequencing Business (2020-2025)
11.4.5 Biocompare Recent Development
11.5 Abveris
11.5.1 Abveris Company Details
11.5.2 Abveris Business Overview
11.5.3 Abveris Ab De Novo Sequencing Introduction
11.5.4 Abveris Revenue in Ab De Novo Sequencing Business (2020-2025)
11.5.5 Abveris Recent Development
11.6 Rapid Novor
11.6.1 Rapid Novor Company Details
11.6.2 Rapid Novor Business Overview
11.6.3 Rapid Novor Ab De Novo Sequencing Introduction
11.6.4 Rapid Novor Revenue in Ab De Novo Sequencing Business (2020-2025)
11.6.5 Rapid Novor Recent Development
11.7 GenScript
11.7.1 GenScript Company Details
11.7.2 GenScript Business Overview
11.7.3 GenScript Ab De Novo Sequencing Introduction
11.7.4 GenScript Revenue in Ab De Novo Sequencing Business (2020-2025)
11.7.5 GenScript Recent Development
11.8 Absolute Antibody
11.8.1 Absolute Antibody Company Details
11.8.2 Absolute Antibody Business Overview
11.8.3 Absolute Antibody Ab De Novo Sequencing Introduction
11.8.4 Absolute Antibody Revenue in Ab De Novo Sequencing Business (2020-2025)
11.8.5 Absolute Antibody Recent Development
11.9 Curia Global
11.9.1 Curia Global Company Details
11.9.2 Curia Global Business Overview
11.9.3 Curia Global Ab De Novo Sequencing Introduction
11.9.4 Curia Global Revenue in Ab De Novo Sequencing Business (2020-2025)
11.9.5 Curia Global Recent Development
11.10 ProteoGenix
11.10.1 ProteoGenix Company Details
11.10.2 ProteoGenix Business Overview
11.10.3 ProteoGenix Ab De Novo Sequencing Introduction
11.10.4 ProteoGenix Revenue in Ab De Novo Sequencing Business (2020-2025)
11.10.5 ProteoGenix Recent Development
11.11 CiteAb
11.11.1 CiteAb Company Details
11.11.2 CiteAb Business Overview
11.11.3 CiteAb Ab De Novo Sequencing Introduction
11.11.4 CiteAb Revenue in Ab De Novo Sequencing Business (2020-2025)
11.11.5 CiteAb Recent Development
11.12 BIOZOL
11.12.1 BIOZOL Company Details
11.12.2 BIOZOL Business Overview
11.12.3 BIOZOL Ab De Novo Sequencing Introduction
11.12.4 BIOZOL Revenue in Ab De Novo Sequencing Business (2020-2025)
11.12.5 BIOZOL Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Ab De Novo Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Monoclonal Antibodies
 Table 3. Key Players of Polyclonal Antibodies
 Table 4. Global Ab De Novo Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Ab De Novo Sequencing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Ab De Novo Sequencing Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Ab De Novo Sequencing Market Share by Region (2020-2025)
 Table 8. Global Ab De Novo Sequencing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Ab De Novo Sequencing Market Share by Region (2026-2031)
 Table 10. Ab De Novo Sequencing Market Trends
 Table 11. Ab De Novo Sequencing Market Drivers
 Table 12. Ab De Novo Sequencing Market Challenges
 Table 13. Ab De Novo Sequencing Market Restraints
 Table 14. Global Ab De Novo Sequencing Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Ab De Novo Sequencing Market Share by Players (2020-2025)
 Table 16. Global Top Ab De Novo Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ab De Novo Sequencing as of 2024)
 Table 17. Ranking of Global Top Ab De Novo Sequencing Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Ab De Novo Sequencing Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Ab De Novo Sequencing, Headquarters and Area Served
 Table 20. Global Key Players of Ab De Novo Sequencing, Product and Application
 Table 21. Global Key Players of Ab De Novo Sequencing, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Ab De Novo Sequencing Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Ab De Novo Sequencing Revenue Market Share by Type (2020-2025)
 Table 25. Global Ab De Novo Sequencing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Ab De Novo Sequencing Revenue Market Share by Type (2026-2031)
 Table 27. Global Ab De Novo Sequencing Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Ab De Novo Sequencing Revenue Market Share by Application (2020-2025)
 Table 29. Global Ab De Novo Sequencing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Ab De Novo Sequencing Revenue Market Share by Application (2026-2031)
 Table 31. North America Ab De Novo Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Ab De Novo Sequencing Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Ab De Novo Sequencing Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Ab De Novo Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Ab De Novo Sequencing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Ab De Novo Sequencing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Ab De Novo Sequencing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Ab De Novo Sequencing Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Ab De Novo Sequencing Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Ab De Novo Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Ab De Novo Sequencing Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Ab De Novo Sequencing Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Ab De Novo Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Ab De Novo Sequencing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Ab De Novo Sequencing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Nanjing Mingyan Biotechnology Co., Ltd. Company Details
 Table 47. Nanjing Mingyan Biotechnology Co., Ltd. Business Overview
 Table 48. Nanjing Mingyan Biotechnology Co., Ltd. Ab De Novo Sequencing Product
 Table 49. Nanjing Mingyan Biotechnology Co., Ltd. Revenue in Ab De Novo Sequencing Business (2020-2025) & (US$ Million)
 Table 50. Nanjing Mingyan Biotechnology Co., Ltd. Recent Development
 Table 51. Suzhou Jinweizhi Biotechnology Co., Ltd. Company Details
 Table 52. Suzhou Jinweizhi Biotechnology Co., Ltd. Business Overview
 Table 53. Suzhou Jinweizhi Biotechnology Co., Ltd. Ab De Novo Sequencing Product
 Table 54. Suzhou Jinweizhi Biotechnology Co., Ltd. Revenue in Ab De Novo Sequencing Business (2020-2025) & (US$ Million)
 Table 55. Suzhou Jinweizhi Biotechnology Co., Ltd. Recent Development
 Table 56. Beijing Baitai Parker Biotechnology Co., Ltd. Company Details
 Table 57. Beijing Baitai Parker Biotechnology Co., Ltd. Business Overview
 Table 58. Beijing Baitai Parker Biotechnology Co., Ltd. Ab De Novo Sequencing Product
 Table 59. Beijing Baitai Parker Biotechnology Co., Ltd. Revenue in Ab De Novo Sequencing Business (2020-2025) & (US$ Million)
 Table 60. Beijing Baitai Parker Biotechnology Co., Ltd. Recent Development
 Table 61. Biocompare Company Details
 Table 62. Biocompare Business Overview
 Table 63. Biocompare Ab De Novo Sequencing Product
 Table 64. Biocompare Revenue in Ab De Novo Sequencing Business (2020-2025) & (US$ Million)
 Table 65. Biocompare Recent Development
 Table 66. Abveris Company Details
 Table 67. Abveris Business Overview
 Table 68. Abveris Ab De Novo Sequencing Product
 Table 69. Abveris Revenue in Ab De Novo Sequencing Business (2020-2025) & (US$ Million)
 Table 70. Abveris Recent Development
 Table 71. Rapid Novor Company Details
 Table 72. Rapid Novor Business Overview
 Table 73. Rapid Novor Ab De Novo Sequencing Product
 Table 74. Rapid Novor Revenue in Ab De Novo Sequencing Business (2020-2025) & (US$ Million)
 Table 75. Rapid Novor Recent Development
 Table 76. GenScript Company Details
 Table 77. GenScript Business Overview
 Table 78. GenScript Ab De Novo Sequencing Product
 Table 79. GenScript Revenue in Ab De Novo Sequencing Business (2020-2025) & (US$ Million)
 Table 80. GenScript Recent Development
 Table 81. Absolute Antibody Company Details
 Table 82. Absolute Antibody Business Overview
 Table 83. Absolute Antibody Ab De Novo Sequencing Product
 Table 84. Absolute Antibody Revenue in Ab De Novo Sequencing Business (2020-2025) & (US$ Million)
 Table 85. Absolute Antibody Recent Development
 Table 86. Curia Global Company Details
 Table 87. Curia Global Business Overview
 Table 88. Curia Global Ab De Novo Sequencing Product
 Table 89. Curia Global Revenue in Ab De Novo Sequencing Business (2020-2025) & (US$ Million)
 Table 90. Curia Global Recent Development
 Table 91. ProteoGenix Company Details
 Table 92. ProteoGenix Business Overview
 Table 93. ProteoGenix Ab De Novo Sequencing Product
 Table 94. ProteoGenix Revenue in Ab De Novo Sequencing Business (2020-2025) & (US$ Million)
 Table 95. ProteoGenix Recent Development
 Table 96. CiteAb Company Details
 Table 97. CiteAb Business Overview
 Table 98. CiteAb Ab De Novo Sequencing Product
 Table 99. CiteAb Revenue in Ab De Novo Sequencing Business (2020-2025) & (US$ Million)
 Table 100. CiteAb Recent Development
 Table 101. BIOZOL Company Details
 Table 102. BIOZOL Business Overview
 Table 103. BIOZOL Ab De Novo Sequencing Product
 Table 104. BIOZOL Revenue in Ab De Novo Sequencing Business (2020-2025) & (US$ Million)
 Table 105. BIOZOL Recent Development
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources
 Table 109. Authors List of This Report


List of Figures
 Figure 1. Ab De Novo Sequencing Picture
 Figure 2. Global Ab De Novo Sequencing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Ab De Novo Sequencing Market Share by Type: 2024 VS 2031
 Figure 4. Monoclonal Antibodies Features
 Figure 5. Polyclonal Antibodies Features
 Figure 6. Global Ab De Novo Sequencing Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Ab De Novo Sequencing Market Share by Application: 2024 VS 2031
 Figure 8. Academic and Research Institutions Case Studies
 Figure 9. Pharmaceutical and Biotech Companies Case Studies
 Figure 10. Diagnostic and Clinical Laboratories Case Studies
 Figure 11. Other Case Studies
 Figure 12. Ab De Novo Sequencing Report Years Considered
 Figure 13. Global Ab De Novo Sequencing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Ab De Novo Sequencing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Ab De Novo Sequencing Market Share by Region: 2024 VS 2031
 Figure 16. Global Ab De Novo Sequencing Market Share by Players in 2024
 Figure 17. Global Top Ab De Novo Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ab De Novo Sequencing as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Ab De Novo Sequencing Revenue in 2024
 Figure 19. North America Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Ab De Novo Sequencing Market Share by Country (2020-2031)
 Figure 21. United States Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Ab De Novo Sequencing Market Share by Country (2020-2031)
 Figure 25. Germany Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Ab De Novo Sequencing Market Share by Region (2020-2031)
 Figure 33. China Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Ab De Novo Sequencing Market Share by Country (2020-2031)
 Figure 41. Mexico Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Ab De Novo Sequencing Market Share by Country (2020-2031)
 Figure 45. Turkey Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Ab De Novo Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Nanjing Mingyan Biotechnology Co., Ltd. Revenue Growth Rate in Ab De Novo Sequencing Business (2020-2025)
 Figure 49. Suzhou Jinweizhi Biotechnology Co., Ltd. Revenue Growth Rate in Ab De Novo Sequencing Business (2020-2025)
 Figure 50. Beijing Baitai Parker Biotechnology Co., Ltd. Revenue Growth Rate in Ab De Novo Sequencing Business (2020-2025)
 Figure 51. Biocompare Revenue Growth Rate in Ab De Novo Sequencing Business (2020-2025)
 Figure 52. Abveris Revenue Growth Rate in Ab De Novo Sequencing Business (2020-2025)
 Figure 53. Rapid Novor Revenue Growth Rate in Ab De Novo Sequencing Business (2020-2025)
 Figure 54. GenScript Revenue Growth Rate in Ab De Novo Sequencing Business (2020-2025)
 Figure 55. Absolute Antibody Revenue Growth Rate in Ab De Novo Sequencing Business (2020-2025)
 Figure 56. Curia Global Revenue Growth Rate in Ab De Novo Sequencing Business (2020-2025)
 Figure 57. ProteoGenix Revenue Growth Rate in Ab De Novo Sequencing Business (2020-2025)
 Figure 58. CiteAb Revenue Growth Rate in Ab De Novo Sequencing Business (2020-2025)
 Figure 59. BIOZOL Revenue Growth Rate in Ab De Novo Sequencing Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart